CRUK/13/026: CompARE: Phase III randomised controlled trial Comparing Alternative Regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer

Gaunt, Piers (Co-Investigator)
Billingham, Lucinda (Co-Investigator)
Mehanna, Hisham (Principal Investigator)
Bowden, Sarah (Co-Investigator)

Short title	CRUK/13/026: CompARE: Phase III randomised controlled trial Comparing Alternative Regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer
Status	Active
Effective start/end date	1/11/14 → 31/12/25

Funding

ASTRA ZENECA UK LIMITED
Cancer Research Uk
CITY HOSPITAL NHS TRUST

2 Article

CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer
Mehanna, H., Gaunt, P., Kong, A., Hartley, A., Sanghera, P., Forster, M., Sen, M., Paleri, V., Fong, C., Geropantas, D., Srinivasan, D., Garikipati, S., Moleron, R., Casswell, G., Aynsley, E., Ward, A., O'Toole, L., Mirza, A., Firth, C., Humphreys, I., & 2 othersFulton-Lieuw, T. & Nankivell, P., 15 Jan 2024, In: Trials. 25, 50.
Research output: Contribution to journal › Article › peer-review

Open Access
File
16 Downloads (Pure)
Lack of predictive tools for conventional and targeted cancer therapy: barriers to biomarker development and clinical translation
Batis, N., Brooks, J., Payne, K., Sharma, N., Nankivell, P. & Mehanna, H., Sept 2021, In: Advanced Drug Delivery Reviews. 176, 113854.
Research output: Contribution to journal › Article › peer-review

Open Access
File
132 Downloads (Pure)